D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 81 Citations 32,001 186 World Ranking 307 National Ranking 159
Medicine D-index 77 Citations 49,613 161 World Ranking 10861 National Ranking 5800

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Bacteria

His primary areas of study are Microbiology, Candida albicans, Corpus albicans, Immunology and Intensive care medicine. The study incorporates disciplines such as Dermatology, In vitro and In vivo in addition to Microbiology. His studies deal with areas such as Bacterial adhesin, Fungal protein and Cell biology as well as Candida albicans.

As a part of the same scientific family, John E. Edwards mostly works in the field of Immunology, focusing on Itraconazole and, on occasion, Deferoxamine and Disease. John E. Edwards interconnects Posaconazole, Echinocandin and Mycosis in the investigation of issues within Intensive care medicine. John E. Edwards has included themes like Mucormycosis, Fluconazole and Combination therapy in his Mycosis study.

His most cited work include:

  • Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group (3691 citations)
  • Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America (3371 citations)
  • Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America (3371 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Microbiology, Candida albicans, Immunology, Corpus albicans and Mucormycosis. His Microbiology research incorporates themes from In vitro and Mutant, Gene, Fungal protein, Virulence. He combines subjects such as Endothelial stem cell, Bacterial adhesin, Antibody and Vaccination with his study of Candida albicans.

His Immunology research is multidisciplinary, incorporating perspectives in Amphotericin B and Staphylococcus aureus. His Corpus albicans study deals with Cell biology intersecting with Endocytosis. His work deals with themes such as Posaconazole and Intensive care medicine, which intersect with Mycosis.

He most often published in these fields:

  • Microbiology (69.29%)
  • Candida albicans (62.92%)
  • Immunology (44.19%)

What were the highlights of his more recent work (between 2013-2021)?

  • Microbiology (69.29%)
  • Candida albicans (62.92%)
  • Virulence (25.09%)

In recent papers he was focusing on the following fields of study:

His main research concerns Microbiology, Candida albicans, Virulence, Mucormycosis and Immunology. His study in the fields of Corpus albicans and Candida auris under the domain of Microbiology overlaps with other disciplines such as Iron deficiency. The Candida albicans study combines topics in areas such as Recurrent vulvovaginal candidiasis, Antibody and Vaccination.

His research in Virulence intersects with topics in Siderophore, Fungal pathogen and Intracellular. His Mucormycosis research is multidisciplinary, relying on both Fungal protein, Epithelium, Pharmacology and Pathogenesis. His Immunity, Immune system and Vaccine efficacy study, which is part of a larger body of work in Immunology, is frequently linked to Diabetic ketoacidosis, bridging the gap between disciplines.

Between 2013 and 2021, his most popular works were:

  • CotH3 mediates fungal invasion of host cells during mucormycosis (83 citations)
  • A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial. (52 citations)
  • A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial. (52 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Bacteria

John E. Edwards mostly deals with Microbiology, Immunology, Mucormycosis, Immune system and Staphylococcus aureus. His studies in Microbiology integrate themes in fields like Bacterial adhesin and Virulence. His work carried out in the field of Immunology brings together such families of science as Staphylococcal infections and Acidosis.

His Mucormycosis study combines topics in areas such as In vivo, Isavuconazonium, Pharmacology and Fungal protein. He has researched Immune system in several fields, including Staphylococcal Skin Infections, Methicillin-resistant Staphylococcus aureus and Interleukin 22. His research integrates issues of Acquired immune system, Antigen, Bacterial vaccine, Antibiotics and Interleukin in his study of Staphylococcus aureus.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

Helen W. Boucher;George H. Talbot;John S. Bradley;John S. Bradley;John E. Edwards;John E. Edwards.
Clinical Infectious Diseases (2009)

5739 Citations

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Peter G. Pappas;Carol A. Kauffman;David Andes;Daniel K. Benjamin.
Clinical Infectious Diseases (2009)

3964 Citations

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

Ben De Pauw;Thomas J. Walsh;J. Peter Donnelly;David A. Stevens.
Clinical Infectious Diseases (2008)

3691 Citations

The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America

Brad Spellberg;Robert Guidos;David Gilbert;John Bradley;John Bradley.
Clinical Infectious Diseases (2008)

1925 Citations

Guidelines for Treatment of Candidiasis

Peter G. Pappas;John H. Rex;Jack D. Sobel;Scott G. Filler.
Clinical Infectious Diseases (2004)

1877 Citations

Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America

George H. Talbot;John Bradley;John Bradley;John E. Edwards;David Gilbert.
Clinical Infectious Diseases (2006)

1393 Citations

Practice Guidelines for the Treatment of Candidiasis

John H. Rex;Thomas J. Walsh;Jack D. Sobel;Scott G. Filler.
Clinical Infectious Diseases (2000)

1201 Citations

A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia

John H. Rex;John E. Bennett;Alan M. Sugar;Peter G. Pappas.
The New England Journal of Medicine (1994)

1186 Citations

Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management

Brad Spellberg;John Edwards;John Edwards;Ashraf Ibrahim;Ashraf Ibrahim.
Clinical Microbiology Reviews (2005)

1030 Citations

Trends in Antimicrobial Drug Development: Implications for the Future

Brad Spellberg;John H. Powers;Eric P. Brass;Loren G. Miller.
Clinical Infectious Diseases (2004)

1021 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing John E. Edwards

Scott G. Filler

Scott G. Filler

University of California, Los Angeles

Publications: 204

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 198

Dimitrios P. Kontoyiannis

Dimitrios P. Kontoyiannis

The University of Texas MD Anderson Cancer Center

Publications: 192

Olivier Lortholary

Olivier Lortholary

Université Paris Cité

Publications: 152

Oliver A. Cornely

Oliver A. Cornely

University of Cologne

Publications: 146

Russell E. Lewis

Russell E. Lewis

University of Bologna

Publications: 134

Bernhard Hube

Bernhard Hube

Leibniz Association

Publications: 132

Michael A. Pfaller

Michael A. Pfaller

JMI Laboratories

Publications: 118

David R. Andes

David R. Andes

University of Wisconsin–Madison

Publications: 113

Ashraf S. Ibrahim

Ashraf S. Ibrahim

University of California, Los Angeles

Publications: 103

Emmanuel Roilides

Emmanuel Roilides

Aristotle University of Thessaloniki

Publications: 101

John R. Perfect

John R. Perfect

Duke University

Publications: 99

Monica A. Slavin

Monica A. Slavin

Peter MacCallum Cancer Centre

Publications: 95

Patricia Muñoz

Patricia Muñoz

Hospital General Universitario Gregorio Marañón

Publications: 93

Sharon C.-A. Chen

Sharon C.-A. Chen

University of Sydney

Publications: 90

Andreas H. Groll

Andreas H. Groll

Boston Children's Hospital

Publications: 89

Trending Scientists

Mustaque Ahamad

Mustaque Ahamad

Georgia Institute of Technology

Nina Smith

Nina Smith

Aarhus University

Hartwig Höcker

Hartwig Höcker

RWTH Aachen University

Ying-Ling Liu

Ying-Ling Liu

National Tsing Hua University

C. R. Kao

C. R. Kao

National Taiwan University

Walter Doerfler

Walter Doerfler

University of Cologne

Robin M. Andrews

Robin M. Andrews

Virginia Tech

Gérard Goma

Gérard Goma

Institut National des Sciences Appliquées de Toulouse

W. J. Lewis

W. J. Lewis

Agricultural Research Service

Yücel Yılmaz

Yücel Yılmaz

Kadir Has University

Zhiwei Han

Zhiwei Han

Chinese Academy of Sciences

Long-Jun Wu

Long-Jun Wu

Mayo Clinic

Nobuo Masataka

Nobuo Masataka

Kyoto University

Edward Zigler

Edward Zigler

Yale University

Peter Roy-Byrne

Peter Roy-Byrne

University of Washington

Slavoj Žižek

Slavoj Žižek

University of Ljubljana

Something went wrong. Please try again later.